Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07233473Recruiting
Vaginal gel for preventing repeat urinary tract infections
This trial tests a vaginal gel to see if it can prevent frequent urinary tract infections (UTIs) in women. It may help if you have had at least 4 UTIs in the past year or 2 in the past 6 months.
VilleurbanneAges 18–84 - NCT07233499RecruitingPhase 2
Nebivolol for heart protection during breast cancer treatment
This trial tests if the drug nebivolol can protect the heart from damage caused by trastuzumab (Herceptin) in women with HER2-positive breast cancer. If effective, it may help prevent heart problems while still allowing cancer treatment.
CairoAges 18–65 - NCT07234292Recruiting
Patient satisfaction with Blephaderm after eyelid surgery
This trial tests how satisfied patients are with using Blephaderm, a complementary care product, after eyelid surgery (blepharoplasty or ptosis repair). It aims to help improve recovery and comfort.
ParisAges 18 years+ - NCT07234422RecruitingPhase 3
Selenium and CoQ10 for heart failure
This study tests whether adding selenium and CoQ10 (two natural supplements) to standard heart failure treatment helps people with chronic heart failure feel better and improve their health. Researchers are using a registry-based approach to track participants in the Netherlands.
AlkmaarAges 18 years+ - NCT07234968Recruiting
Stent vs no stent after bladder removal surgery
This study looks at whether leaving a small tube (ureteral stent) in place after bladder removal helps recovery. It compares people who get a stent to those who don't, focusing on problems like leaks or infections after surgery.
Philadelphia, PennsylvaniaAges 18–85 - NCT07236177RecruitingEarly Phase 1
Enzyme test for early breast, lung, or pancreatic cancer
This study tests a new blood test that measures enzyme activity to detect localized cancer. It is for people with newly diagnosed, untreated breast, lung, or pancreatic cancer, as well as healthy volunteers.
PoitiersAges 18 years+ - NCT07236489Recruiting
New pacing method after TAVI for heart block
This trial compares a newer pacing technique (left bundle branch area stimulation) with standard pacing in people who need a pacemaker after TAVI (a valve replacement procedure). It aims to see if the newer method works better for keeping the heart's rhythm stable.
Brest, FinistèreAges 18 years+ - NCT07236866Recruiting
Measuring walking and moving skills in older patients
This study checks a new way to measure how well older adults can move and transfer (like getting out of bed or a chair). It looks at patients in a French geriatric hospital to see if the measurement is helpful.
Grenoble, IsereAges 75 years+ - NCT07236996Recruiting
Air purifier health effects in preterm infants after discharge
This trial tests if using an air purifier at home helps improve the health of babies who were born early (before 37 weeks of pregnancy). The goal is to see if cleaner air reduces breathing problems or other issues after they leave the hospital.
Kaohsiung CityAges Up to 6 years - NCT07237464RecruitingPhase 1
Safety study of GB18 injection in healthy adults
This early-phase trial tests a new injection called GB18 in healthy adults to see if it is safe and how the body processes it. It may help researchers understand how to treat conditions that involve the immune system.
Beijing, Beijing MunicipalityAges 18–55 - NCT07237568RecruitingPhase 3
Testing LNK01001 for active ankylosing spondylitis
This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.
BeijingAges 18 years+ - NCT07237685Recruiting
Diabetes and heart artery plaque progression study
This study uses a follow-up CT scan of your heart arteries to see how diabetes-related plaque buildup changes over time. It may help researchers understand how well current diabetes treatments are protecting your heart.
AmsterdamAges 18 years+ - NCT07238868RecruitingPhase 2
Long-term safety study of CB03-154 for epilepsy
This study is a long-term follow-up for people with epilepsy who already completed a previous trial of the drug CB03-154. It checks if the drug remains safe and effective over more time.
Melbourne, VictoriaAges 18–70 - NCT07239245RecruitingPhase 2
TACE plus immunotherapy for high-risk liver cancer before surgery
This trial tests whether a combination of two therapies—targeted chemotherapy delivered directly to the liver (TACE) plus immunotherapy (atezolizumab) and a targeted drug (bevacizumab)—can keep liver cancer from coming back after surgery. It is for people whose tumors can be surgically removed but are at high risk of recurrence.
Beijing, Beijing MunicipalityAges 18–75 - NCT07239466RecruitingPhase 2
Ketone supplement with radiation and chemo for rectal cancer
This study tests a combination of a special diet supplement (beta-hydroxybutyrate), short radiation therapy, immunotherapy, and chemotherapy before surgery for locally advanced rectal cancer. The goal is to see if this approach helps shrink the tumor and improve treatment outcomes.
Wuhan, HubeiAges 18–75 - NCT07239505Recruiting
Pre-operative medication for tooth pain relief study
This trial tests a medication called Trinase, given before a root canal, to see if it reduces pain after the procedure compared to a placebo. It may help if you have a painful tooth that needs treatment.
Al Fayyum, Faiyum GovernorateAges 18–50 - NCT07239791Recruiting
Does a low-dose medication affect how we learn?
This study tests whether a very low dose of a medication called atomoxetine, which affects a brain chemical called noradrenaline, can help with how people learn. It is for right-handed adults who are generally healthy and not taking other medications.
ParisAges 18–39 - NCT07241234RecruitingPhase 1
Study of an experimental drug for phenylketonuria (PKU)
This trial tests an investigational drug (AG-181) for people with PKU who have a specific genetic change (R408W mutation). It aims to check if the drug is safe and how it works in your body.
Indianapolis, IndianaAges 18–69 - NCT07241572Recruiting
Heart injury risk during below-knee surgery
This trial checks for heart muscle injury during surgery on the lower leg (below the knee). It helps doctors understand how to better protect patients having this type of operation.
AnkaraAges 18 years+ - NCT07241910RecruitingPhase 1
Testing the safety of SYH2061 in healthy volunteers
This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.
Hefei, AnhuiAges 18–55 - NCT07241923RecruitingPhase 1
SYH2070 injection safety study for high triglycerides and high cholesterol
This study tests a new injection called SYH2070 for people with high triglycerides and high LDL cholesterol. The goal is to see if a single dose is safe and how the body processes the medication. It is for people who have not been on cholesterol-lowering drugs recently.
Shijiazhuang, HebeiAges 18–60 - NCT07242833Recruiting
Does season affect biological age? A study in adults.
This study looks at how the changing seasons might affect your biological age—a measure of how well your body is aging. If you are over 40 and generally healthy, you may help us understand how factors like time of year influence aging.
Lausanne, CHAges 40 years+ - NCT07243249Recruiting
Quick virus test to guide antibiotic use
This study tests whether a quick test for COVID-19, flu, and RSV can help doctors avoid giving antibiotics when they aren't needed. It's for people with fever or chest infection symptoms who are not sick enough to be hospitalized.
GarchesAges 1 year+ - NCT07245420Recruiting
Heart health study for childhood cancer survivors
This study checks heart health in adult survivors of childhood cancer who had certain heart-related treatments years ago. If you haven't had a heart ultrasound in the last 5 years, you may be able to help researchers learn how to better monitor heart health.
Memphis, TennesseeAges 26 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.